COVID-19: NIAID Regulatory Support Center
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 75N93021D00038-0-759302400001-2
Grant search
Key facts
Disease
COVID-19Start & end year
20242025Known Financial Commitments (USD)
$63,400Funder
National Institutes of Health (NIH)Principal Investigator
N/A
Research Location
United States of AmericaLead Research Institution
TECHNICAL RESOURCES INTERNATIONAL, INC.Research Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The purpose of this contract is to provide regulatory expertise and support to operate and manage the NIAID Regulatory Support Center (RSC) to provide a wide range of clinical research activities and programs for NIAID. The RSC provides comprehensive regulatory support to: 1) perform NIAID-funded and NIAID-sponsored domestic and international clinical trial research; 2) provide training in key functions of clinical trial research to NIAID staff, investigators, and collaborators; and 3) maintain all contract-associated data and records in the NIAID-Clinical Research Management System (N-CRMS), including the electronic submission of required regulatory information. This project will provide regulatory support services for the COVID-19 clinical trial ACTIV-2 (Outpatient Monoclonal Antibodies And Other Therapies).